• Explore /
  • Poster
  • / Discovery and validation of a genomic signature to identify women with early-stage invasive breast cancer who may safely omit adjuvant radiotherapy after breast-conserving surgery.

Discovery and validation of a genomic signature to identify women with early-stage invasive breast cancer who may safely omit adjuvant radiotherapy after breast-conserving surgery.

Abstract Video & Slides Poster

Authors

null

Martin Sjöström

University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Martin Sjöström , S. Laura Chang , Linda Hartman , Erik Holmberg , Felix Y Feng , Corey Wayne Speers , Lori J. Pierce , Per Malmström , Mårten Fernö , Per Karlsson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Local-Regional Therapy

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 512)

DOI

10.1200/JCO.2021.39.15_suppl.512

Abstract #

512

Abstract Disclosures

Similar Posters

First Author: Julia R. White

Poster

2022 ASCO Quality Care Symposium

Measuring geographic variation in quality and equity of breast cancer care.

Measuring geographic variation in quality and equity of breast cancer care.

First Author: Katherine Elizabeth Reeder-Hayes

First Author: Sara A. Hurvitz

First Author: Sara A. Hurvitz